THAO TRAN: Open Payments
NPI 1124531447 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$60 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $37 · 2025 $60
Food & beverage: $60
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $29 |
| Alcresta Therapeutics, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: REZDIFFRA, RELIZORB, SPEVIGO.
Industry payments across AL — which companies pay providers there.
